Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

UNCOVERED: Why nkarta stock is soaring today - Caught on Camera

Nkarta Inc (NASDAQ:NKTX) shares are trading higher Monday morning after the company announced positive preliminary Phase 1 data from independent dose finding studies.

The positive data was for the company's two lead chimeric antigen receptor natural killer cell therapy candidates, NKX101 and NKX019, in two distinct groups of hematologic malignancies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.